Cimetidine and Gastric Cancer

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 1979 May 12

PMID 86721

Citations 22

Authors

J B Elder

P C Ganguli

I E Gillespie

Affiliations

Soon will be listed here.

Abstract

Three patients with dyspeptic symptoms who were being treated with the H2-receptor blocking drug, cimetidine, were later found to have gastric carcinoma. It was not possible to determine whether the association was fortuitous, whether the drug had masked the neoplastic change, or whether it was involved in some other way. Repeated clinical and endoscopic evaluation is essential in patients on this treatment for any length of time.

Citing Articles

PPIs and gastric cancer: any causal relationship?.

Crafa P, Franceschi M, Rodriguez-Castro K, Franzoni L, Russo M, Brandimarte G Acta Biomed. 2023; 94(3):e2023096.

PMID: 37326271 PMC: 10308480. DOI: 10.23750/abm.v94i3.14105.

Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme V Ecancermedicalscience. 2014; 8:485.

PMID: 25525463 PMC: 4268104. DOI: 10.3332/ecancer.2014.485.

Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.

Ubukata H, Nagata H, Tabuchi T, Konishi S, Kasuga T, Tabuchi T Gastric Cancer. 2011; 14(1):4-12.

PMID: 21249411 DOI: 10.1007/s10120-011-0005-9.

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Garcia Rodriguez L, Lagergren J, Lindblad M Gut. 2006; 55(11):1538-44.

PMID: 16785284 PMC: 1860118. DOI: 10.1136/gut.2005.086579.

Adverse effects of anti-ulcer drugs.

Henry D, Langman M Drugs. 1981; 21(6):444-59.

PMID: 7249945 DOI: 10.2165/00003495-198121060-00004.